SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-281237
Filing Date
2018-09-24
Accepted
2018-09-24 16:33:58
Documents
6
Period of Report
2018-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d628688d8k.htm 8-K 18433
2 EX-10.1 d628688dex101.htm EX-10.1 52832
3 EX-10.2 d628688dex102.htm EX-10.2 52960
4 GRAPHIC g628688g0922200050806.jpg GRAPHIC 13774
5 GRAPHIC g628688g0922200050977.jpg GRAPHIC 5511
6 GRAPHIC g628688g0922200520378.jpg GRAPHIC 13774
  Complete submission text file 0001193125-18-281237.txt   171527
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 181083880
SIC: 2834 Pharmaceutical Preparations